small RNA binding exonuclease protection factor La like 5, pseudogeneGenealiases: []
Q-omics provides the consensus-scored SSBL5P profile across patient tissues and cancer cell-line models. SSBL5P expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, SSBL5P is differentially expressed in 8, with the highest sampling consensus in COAD. Additionally, SSBL5P RNA expression shows 9,087 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UVM, and COAD as cancer lineages where SSBL5P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SSBL5P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes SSBL5P survival associations across molecular data types. SSBL5P RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SSBL5P RNA expression–survival associations across cancer types. High SSBL5P expression shows unfavorable associations in UVM, MESO, KIRC, ACC and LGG, but favorable associations in SKCM. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for SSBL5P RNA expression.
This table summarizes SSBL5P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for SSBL5P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. SSBL5P shows lower tumor expression in THCA and higher tumor expression in COAD, BLCA, HNSC, LUSC and STAD. The COAD box plot shows higher SSBL5P RNA expression in tumor versus normal tissue (log2 FC = +0.187, t-test p < 0.001).
This table shows molecular features associated with SSBL5P in patient tissues and cancer cell lines. In patient samples, SSBL5P shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
